Business Description
CARsgen Therapeutics Holdings Limited is a Shanghai-based biopharmaceutical company founded in 2014 that develops advanced cell therapies designed to fight blood cancers, solid tumors, and autoimmune conditions. The company's work centers on CAR-T technology, which involves engineering a patient's own immune cells to seek out and destroy diseased cells. Its most mature product targets multiple myeloma, while a broad pipeline of additional treatments for cancers of the stomach, liver, and pancreas ? as well as autoimmune diseases ? are progressing through various stages of clinical testing.
